China: Chinese Patent Office Hands Down Key Ruling On Pharma Patent Requirements - Rouse
Friday, 15 March 2024
The Patent Re-examination Board of China's National Intellectual Property Administration (PRB) recently issued a decision to invalidate two "orange book" patents owned by AbbVie.
|
||||
You Might Like |
||||
